Franklin Genomic Advancements ETF (HELX)
Upgrades & Downgrades
Latest HELX news
Why Now Could Be The Time To Consider Neuroscience Investments
27 August 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic...
Hop on HELX for Potential Biotech M&A
10 June 2022
Blame inflation and rising interest rates, among other factors, but biotechnology mergers and acquisitions activity remains lethargic. That's despite a slump in biotech stocks dating back to early 202...
Invest in the Fully Mapped Human Genome With This ETF
18 April 2022
Scientists have completed mapping the human genome. New research from the Telomere-to-Telomere (T2T) Consortium, a loose collaborative of about 100 scientists, shows that the team has completed a chal...